CANNAPHARMARX, INC. Convertible Debt
CANNAPHARMARX, INC. (CPMD) had Convertible Debt of $1.02 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2026-03-31
- 2025-12-31: Convertible Debt $1.02M.
- 2025-09-30: Convertible Debt $1.02M.
- 2025-06-30: Convertible Debt $1.30M.
- 2025-03-31: Convertible Debt $1.30M.
| Period end | Convertible Debt | Convertible Debt as first filed |
|---|---|---|
| 2025-12-31 | $1.02M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.30M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-16 | |
| 2024-12-31 | $1.30M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.15M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $1.22M 10-Q · filed 2024-06-25 | |
| 2023-12-31 | $1.52M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $1.38M 10-Q · filed 2023-10-13 | |
| 2023-03-31 | $1.34M 10-Q · filed 2023-09-22 | |
| 2022-12-31 | $1.14M 10-K · filed 2025-04-10 | $1.30M 10-K · filed 2023-09-01 |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $1.27M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $943.02K 10-Q · filed 2023-11-17 | |
| 2021-09-30 | $1.04M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.09M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.49M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.66M 10-K · filed 2022-04-15 | |
| 2019-12-31 | $1.55M 10-K · filed 2021-04-14 |